Fig. 2.
Retroviral transduction of the NY-ESO-1 TCR generates a high percentage of antigen-specific T cells, over a 10-day culture, prior to ACT. (A) Populations skew toward a CD3/CD8 cytotoxic T cell phenotype over 10 days of expansion. The percentages of CD8+ and CD4+ T cell populations were estimated by flow cytometry at 2 days (45.6% and 48.6%, respectively) and at 10 days (78.0% and 12.5%, respectively) following transduction and expansion in medium supplemented with 300 IU/mL of IL-2. APC, allophycocyanin. (B) Expression of TCRvβ13.1 by CD8+ T cells at 2 days (75.3%) and 10 days (86.1%) posttransduction compared with nontransduced T cells. Data shown are representative of one experiment repeated 4 times with similar findings. FITC, fluorescein isothiocyanate.

Retroviral transduction of the NY-ESO-1 TCR generates a high percentage of antigen-specific T cells, over a 10-day culture, prior to ACT. (A) Populations skew toward a CD3/CD8 cytotoxic T cell phenotype over 10 days of expansion. The percentages of CD8+ and CD4+ T cell populations were estimated by flow cytometry at 2 days (45.6% and 48.6%, respectively) and at 10 days (78.0% and 12.5%, respectively) following transduction and expansion in medium supplemented with 300 IU/mL of IL-2. APC, allophycocyanin. (B) Expression of TCRvβ13.1 by CD8+ T cells at 2 days (75.3%) and 10 days (86.1%) posttransduction compared with nontransduced T cells. Data shown are representative of one experiment repeated 4 times with similar findings. FITC, fluorescein isothiocyanate.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close